Navigation Links
Progesterone changes may cause cognitive impairment of Alzheimer's disease patients
Date:12/6/2013

Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta (Aβ) peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods. To gain a better understanding on the role of neuroactive steroids in the pathology of Alzheimer's disease, Dr. Sha Liu and colleagues from Hebei Medical University, China investigated the effect of progesterone administration against Aβ2535-induced impairment in vivo. In their study, intracerebral injection of aggregated Aβ2535 into the bilateral hippocampal CA1 region impaired learning and memory abilities of rats, accompanied by reduced levels of progesterone. Treatment of these Alzheimer's disease rats with exogenous progesterone could reverse cognitive impairment. Therefore, this study, published in the Neural Regeneration Research (Vol. 8, No. 30, 2013), provides a possible therapeutic strategy for Alzheimer's disease via neuroactive steroids, particularly progesterone.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert

Page: 1

Related biology news :

1. Progesterone may be why pregnant women are more vulnerable to certain infections
2. State of Michigan adopts NIHs PRB progesterone therapy to combat infant mortality
3. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
4. Rapid climate changes, but with a 120 year time lag
5. Your first hug: How the early embryo changes shape
6. Men with prostate cancer who ate a low-fat fish oil diet showed changes in their cancer tissue
7. Changes to fisheries legislation have removed habitat protection for most fish species in Canada
8. Small changes in ag practices could reduce produce-borne illness
9. Despite menu changes, calorie and sodium levels in chain restaurant entrees remain the same overall
10. Epigenetic changes observed in blood may point to early stages in Parkinson disease
11. Little changes -- large effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... December 03, 2016 , ... Microbial genomics leader uBiome is ... has been made to Dr. Renato Polimanti of Yale University School of Medicine, ... microbiome. Grant proposals have been vetted by the company’s scientific review committee. ...
(Date:12/2/2016)... ... December 02, 2016 , ... In ... cervical and lumbar disc production, company President, Jake Lubinski will be traveling to ... the AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ACEA Biosciences, Inc. ... Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, ... an update on the phase I/II clinical trials for AC0010 in patients with advanced ...
Breaking Biology Technology: